Loading companies…
AB
Anaconda Biomed
Spain · Healthtech · Hardware
Anaconda Biomed develops funnel-shaped thrombectomy catheters that help neurointerventional physicians remove clots during treatment of large-vessel-occlusion stroke.
Product and applications
Anaconda Biomed’s ANA catheter platform is designed for mechanical thrombectomy in acute ischemic stroke. Its self-expanding funnel temporarily restricts blood flow around a clot, supporting aspiration during retrieval and helping capture clot material while reducing the risk of fragments traveling downstream.
The portfolio is built for neurointerventional teams and includes the CE-marked ANA5 catheter; the company is also developing additional devices and conducting the ATHENA pivotal US IDE study. The study is evaluating the safety and performance of the ANA Funnel Catheter, which remains investigational in the United States.
- Product focus
- Funnel-catheter platform for neurovascular thrombectomy
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | $56M | Omega Funds — LeadAsabys (Sabadell Asabys II) — ParticipantCDTI (SICC Innvierte) — ParticipantCo-Investment Fund (FOCO) — ParticipantYsios Capital — Participant |
Investors
Omega FundsLed Series CAsabys (Sabadell Asabys II)Joined Series CCDTI (SICC Innvierte)Joined Series CCo-Investment Fund (FOCO)Joined Series CYsios CapitalJoined Series CCoverage
Sep 23, 2026Anaconda Biomed · Series CSimilar companies
GMGeneral MedicineAn online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.$120M · Series B
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
AventixAventix builds sensor-based analytical instruments for laboratories. Its first product, Scarlett 01, measures liquid volumes across microplate wells without touching the sample, helping R&D teams check dispensing quality and catch volume variation before it affects assay results.€1.2M · Pre-seed